National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Revolade® for the treatment adult patients with acquired severe aplastic anaemia (SAA) who were either refractory to prior immunosuppressive therapy or heavily pre-treated and are unsuitable for haematopoietic stem cell transplantation.

 

Rapid Review

Commenced Completed Outcome
05/02/2016 01/03/2016 Full Pharmacoeconomic Evaluation Not Recommended